UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Climate Impacts on Agriculture: Implications for Crop Production

Agronomy journal, 2011-03, Vol.103 (2), p.351-370

2011

Volltextzugriff (PDF)

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

The New England journal of medicine, 2016-08, Vol.375 (5), p.422-434

2016

Volltextzugriff (PDF)

Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis

Journal of the American Academy of Dermatology, 2012-03, Vol.66 (3), p.369-375

2012

Volltextzugriff (PDF)

Systemic associations of hidradenitis suppurativa

Journal of the American Academy of Dermatology, 2015-11, Vol.73 (5), p.S27-S35

2015

Volltextzugriff (PDF)

Hidradenitis suppurativa: Epidemiology and scope of the problem

Journal of the American Academy of Dermatology, 2015-11, Vol.73 (5), p.S4-S7

2015

Volltextzugriff (PDF)

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

The Lancet (British edition), 2017-07, Vol.390 (10091), p.276-288

2017

Volltextzugriff (PDF)

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

Journal of the American Academy of Dermatology, 2017-03, Vol.76 (3), p.405-417

2017

Volltextzugriff (PDF)

Psoriasis Epidemiology: The Interplay of Genes and the Environment

Journal of investigative dermatology, 2013-02, Vol.133 (2), p.287-289

2013

Volltextzugriff (PDF)

Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis

Journal of the American Academy of Dermatology, 2014-12, Vol.71 (6), p.1144-1150

2014

Volltextzugriff (PDF)

Theory and performance of an infrared heater for ecosystem warming

Global change biology, 2005-11, Vol.11 (11), p.2041-2056

Kimball, B. A.

2005

Volltextzugriff (PDF)

Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment

British journal of dermatology (1951), 2014-12, Vol.171 (6), p.1434-1442

2014

Volltextzugriff (PDF)

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)

British journal of dermatology (1951), 2014-07, Vol.171 (1), p.137-147

2014

Volltextzugriff (PDF)

Wheat Growth Response to Increased Temperature from Varied Planting Dates and Supplemental Infrared Heating

Agronomy journal, 2012, Vol.104 (1), p.7-16

2012

Volltextzugriff (PDF)

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

The New England journal of medicine, 2015-10, Vol.373 (14), p.1318-1328

2015

Volltextzugriff (PDF)

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study

British journal of dermatology (1951), 2011-11, Vol.165 (5), p.1066-1073

2011

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

The Lancet (British edition), 2008-05, Vol.371 (9625), p.1665-1674

2008

Volltextzugriff (PDF)

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

Arthritis & rheumatology (Hoboken, N.J.), 2018-09, Vol.70 (9), p.1399-1407

2018

Volltextzugriff (PDF)

Dermatologic inflammatory conditions require high loading and maintenance doses of biologic therapy

Journal of the European Academy of Dermatology and Venereology, 2022-10, Vol.36 (10), p.e786-e788

2022

Volltextzugriff (PDF)

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years

British journal of dermatology (1951), 2012-04, Vol.166 (4), p.861-872

2012

Volltextzugriff (PDF)

Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial

British journal of dermatology (1951), 2014-11, Vol.171 (5), p.1215-1219

2014

Volltextzugriff (PDF)

Safety of guselkumab in patients with moderate‐to‐severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies

British journal of dermatology (1951), 2019-05, Vol.180 (5), p.1039-1049

2019

Volltextzugriff (PDF)

Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States

Journal of the American Academy of Dermatology, 2016-01, Vol.74 (1), p.190-192

2016

Volltextzugriff (PDF)

Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis

Journal of the American Academy of Dermatology, 2017-06, Vol.76 (6), p.1198-1200.e1

2017

Volltextzugriff (PDF)

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy

Journal of the American Academy of Dermatology, 2020-10, Vol.83 (4), p.1215-1218

2020

Volltextzugriff (PDF)

Transcriptomic analysis of human skin wound healing and rejuvenation following ablative fractional laser treatment

PloS one, 2021-11, Vol.16 (11), p.e0260095-e0260095

2021

Volltextzugriff (PDF)

1 – 25 von 2.547

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.131)
Mit Volltextzugriff
(2.025)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.328)
Life Sciences & Biomedicine
(1.076)
Humans
(677)
Biological And Medical Sciences
(450)
Female
(416)
Male
(381)
Adult
(303)
Dermatology
(303)
Physical Sciences
(288)
Medical Sciences
(251)
Middle Aged
(245)
Fundamental And Applied Biological Sciences. Psychology
(206)
Animals
(160)
Aged
(135)
Adolescent
(126)
Agriculture
(118)
Carbon Dioxide
(118)
Agronomy. Soil Science And Plant Productions
(107)
Social Sciences
(100)
Environmental Sciences & Ecology
(99)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Climate Impacts on Agriculture: Implications for Crop Production

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis

Systemic associations of hidradenitis suppurativa

Hidradenitis suppurativa: Epidemiology and scope of the problem

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

Psoriasis Epidemiology: The Interplay of Genes and the Environment

Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis

Theory and performance of an infrared heater for ecosystem warming

Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)

Wheat Growth Response to Increased Temperature from Varied Planting Dates and Supplemental Infrared Heating

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

Dermatologic inflammatory conditions require high loading and maintenance doses of biologic therapy

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years

Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial

Safety of guselkumab in patients with moderate‐to‐severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies

Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States

Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy

Transcriptomic analysis of human skin wound healing and rejuvenation following ablative fractional laser treatment

Suchergebnisse filtern